A single and repeat dosing study of the safety, drug exposure, and clinical activity of R-3750 in patients with mild to moderate ulcerative colitis
Primary Objective
To determine safety and tolerability of orally delivered R-3750 in mild to moderate patients with ulcerative colitis
Description
A single and repeat dosing study of the safety, drug exposure, and clinical activity of R-3750 in patients with mild to moderate ulcerative colitis
Details
Age
Adult
Type of Study
Treatment
Scope
National
Locations
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Waseem Ahmed, MD
Study ID
Protocol Number: 23-0025
More information available at ClinicalTrials.gov: NCT05666960
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers